Terms: = Thyroid cancer AND SERPINE1, PAI, PAI-1, PAI1, PLANH1
33 results:
1. Exosomal miR-361-3p promotes the viability of breast cancer cells by targeting ETV7 and BATF2 to upregulate the pai-1/ERK pathway.
Li Y; Fan L; Yan A; Ren X; Zhao Y; Hua B
J Transl Med; 2024 Jan; 22(1):112. PubMed ID: 38282047
[TBL] [Abstract] [Full Text] [Related]
2. A signature of circadian rhythm genes in driving anaplastic thyroid carcinoma malignant progression.
Xu T; Jin T; Lu X; Pan Z; Tan Z; Zheng C; Liu Y; Hu X; Ba L; Ren H; Chen J; Zhu C; Ge M; Huang P
Cell Signal; 2022 Jul; 95():110332. PubMed ID: 35430345
[TBL] [Abstract] [Full Text] [Related]
3. Matriptase-2/NR4A3 axis switches TGF-β action toward suppression of prostate cancer cell invasion, tumor growth, and metastasis.
Lin HY; Ko CJ; Lo TY; Wu SR; Lan SW; Huang CA; Lin YC; Lin HH; Tu HF; Lee CF; Hsiao PW; Huang HP; Chen MJ; Chang KH; Lee MS
Oncogene; 2022 May; 41(20):2833-2845. PubMed ID: 35418692
[TBL] [Abstract] [Full Text] [Related]
4. Cortisol Deficiency in Lenvatinib Treatment of thyroid cancer: An Underestimated Common Adverse Event.
Monti S; Presciuttini F; Deiana MG; Motta C; Mori F; Renzelli V; Stigliano A; Toscano V; Pugliese G; Poggi M
Thyroid; 2022 Jan; 32(1):46-53. PubMed ID: 34663079
[No Abstract] [Full Text] [Related]
5. RGD-functionalised melanin nanoparticles for intraoperative photoacoustic imaging-guided breast cancer surgery.
Liu JJ; Wang Z; Nie LM; Zhu YY; Li G; Lin LL; Chen M; Zhang GJ
Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):847-860. PubMed ID: 34505945
[TBL] [Abstract] [Full Text] [Related]
6. Pancancer survival analysis of cancer hallmark genes.
Nagy Á; Munkácsy G; Győrffy B
Sci Rep; 2021 Mar; 11(1):6047. PubMed ID: 33723286
[TBL] [Abstract] [Full Text] [Related]
7. [IgG4-related disease: about 3 cases].
Abid H; Alaoui MEHHBE; Lamrani MYA; Figuigui M; Ahmed BC; Lahmidani N; Yousfi ME; Benajah DA; Maaroufi M; Abkari ME; Ibrahimi SA; Aqodad N
Pan Afr Med J; 2020; 36():364. PubMed ID: 33235641
[TBL] [Abstract] [Full Text] [Related]
8. Using The cancer Genome Atlas data to refine the 8th edition of the American Joint Committee on cancer staging for papillary thyroid carcinoma.
Poma AM; Macerola E; Torregrossa L; Elisei R; Santini F; Basolo F
Endocrine; 2021 Apr; 72(1):140-146. PubMed ID: 32915437
[TBL] [Abstract] [Full Text] [Related]
9. Role of miR-30a-3p Regulation of Oncogenic Targets in Pancreatic Ductal Adenocarcinoma Pathogenesis.
Shimomura H; Okada R; Tanaka T; Hozaka Y; Wada M; Moriya S; Idichi T; Kita Y; Kurahara H; Ohtsuka T; Seki N
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899691
[TBL] [Abstract] [Full Text] [Related]
10. Six-gene signature for predicting survival in patients with head and neck squamous cell carcinoma.
Wang J; Chen X; Tian Y; Zhu G; Qin Y; Chen X; Pi L; Wei M; Liu G; Li Z; Chen C; Lv Y; Cai G
Aging (Albany NY); 2020 Jan; 12(1):767-783. PubMed ID: 31927533
[TBL] [Abstract] [Full Text] [Related]
11. Molecular biomarkers of Graves' ophthalmopathy.
Longo CM; Higgins PJ
Exp Mol Pathol; 2019 Feb; 106():1-6. PubMed ID: 30414981
[TBL] [Abstract] [Full Text] [Related]
12. Primary Adrenal Insufficiency During Lenvatinib or Vandetanib and Improvement of Fatigue After Cortisone Acetate Therapy.
Colombo C; De Leo S; Di Stefano M; Vannucchi G; Persani L; Fugazzola L
J Clin Endocrinol Metab; 2019 Mar; 104(3):779-784. PubMed ID: 30383218
[TBL] [Abstract] [Full Text] [Related]
13. Photoacoustic Imaging as an Early Biomarker of Radio Therapeutic Efficacy in Head and Neck cancer.
Rich LJ; Miller A; Singh AK; Seshadri M
Theranostics; 2018; 8(8):2064-2078. PubMed ID: 29721063
[TBL] [Abstract] [Full Text] [Related]
14. ING2, a tumor associated gene, enhances pai‑1 and HSPA1A expression with HDAC1 and mSin3A through the PHD domain and C‑terminal.
Ohkouchi C; Kumamoto K; Saito M; Ishigame T; Suzuki SI; Takenoshita S; Harris CC
Mol Med Rep; 2017 Nov; 16(5):7367-7374. PubMed ID: 28944862
[TBL] [Abstract] [Full Text] [Related]
15. Pathways Regulating Spheroid Formation of Human Follicular thyroid cancer Cells under Simulated Microgravity Conditions: A Genetic Approach.
Riwaldt S; Bauer J; Wehland M; Slumstrup L; Kopp S; Warnke E; Dittrich A; Magnusson NE; Pietsch J; Corydon TJ; Infanger M; Grimm D
Int J Mol Sci; 2016 Apr; 17(4):528. PubMed ID: 27070589
[TBL] [Abstract] [Full Text] [Related]
16. Notch1 Signaling Regulates the Aggressiveness of Differentiated thyroid cancer and Inhibits serpine1 Expression.
Yu XM; Jaskula-Sztul R; Georgen MR; Aburjania Z; Somnay YR; Leverson G; Sippel RS; Lloyd RV; Johnson BP; Chen H
Clin Cancer Res; 2016 Jul; 22(14):3582-92. PubMed ID: 26847059
[TBL] [Abstract] [Full Text] [Related]
17. Light in and sound out: emerging translational strategies for photoacoustic imaging.
Zackrisson S; van de Ven SMWY; Gambhir SS
Cancer Res; 2014 Feb; 74(4):979-1004. PubMed ID: 24514041
[TBL] [Abstract] [Full Text] [Related]
18. Urokinase plasminogen activator and its inhibitor type-1 as prognostic factors in differentiated thyroid carcinoma patients.
Horvatic Herceg G; Herceg D; Kralik M; Kulic A; Bence-Zigman Z; Tomic-Brzac H; Bracic I; Kusacic-Kuna S; Prgomet D
Otolaryngol Head Neck Surg; 2013 Oct; 149(4):533-40. PubMed ID: 23835563
[TBL] [Abstract] [Full Text] [Related]
19. Relationship between leptin receptor and polycystic ovary syndrome.
Li L; Lee KJ; Choi BC; Baek KH
Gene; 2013 Sep; 527(1):71-4. PubMed ID: 23769971
[TBL] [Abstract] [Full Text] [Related]
20. The urokinase plasminogen activating system in thyroid cancer: clinical implications.
Baldini E; Sorrenti S; D'Armiento E; Di Matteo FM; Catania A; Ulisse S
G Chir; 2012 Oct; 33(10):305-10. PubMed ID: 23095556
[TBL] [Abstract] [Full Text] [Related]
[Next]
